EICHORCondition: Nonalcoholic Fatty Liver Disease · Non-alcoholic Fatty Liver Disease · Sponsor: GlaxoSmithKline
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of this study is to measure improvements in liver fibrosis and inflammation with GSK4532990 compared with placebo in participants with NASH and advanced fibrosis on biopsy (F3 or F4). The study duration will be up to 76 weeks including the screening period. The treatment duration will be up to 52 weeks.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| GSK Investigational Site | Homewood, Alabama, United States | — |
| GSK Investigational Site | Chandler, Arizona, United States | — |
| GSK Investigational Site | Chandler, Arizona, United States | — |
| GSK Investigational Site | Mesa, Arizona, United States | — |
| GSK Investigational Site | Jonesboro, Arkansas, United States | — |
| GSK Investigational Site | North Little Rock, Arkansas, United States | — |
| GSK Investigational Site | Huntington Park, California, United States | — |
| GSK Investigational Site | La Jolla, California, United States | — |
| GSK Investigational Site | Orange, California, United States | — |
| GSK Investigational Site | Poway, California, United States | — |
| GSK Investigational Site | Rialto, California, United States | — |
| GSK Investigational Site | Sacramento, California, United States | — |
+ 158 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05583344